Month: June 2020

Press release – No. 08 / 2020Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes Association

The Annual General Meeting and Extraordinary General Meeting of shareholders of ArcelorMittal (“General Meetings”) held today approved all resolutions by a strong majority.Luxembourg 13 June 2020 (13:00 CET) – 68% of the voting rights were represented at the General Meetings. In view of the Covid-19 outbreak, the Board of Directors of ArcelorMittal (the “Company”) had decided to hold this year’s General Meetings by virtual-only format, as permitted by Luxembourg law. Arrangements were made to allow shareholders to vote electronically and by proxy voting. The results of the votes will be posted shortly on www.arcelormittal.com  under “Investors – Equity investors – Shareholders-events – AGM – Annual General Meeting and Extraordinary General Meeting of shareholders, 13 June 2020” where the full documentation regarding the General...

           13 June 2020Below please find average gross operated production in May 2020 and corresponding numbers for April 2020.Barrels of oil equivalents per dayBarrels of oil per dayAs of Ma 5th, Puli C fields have been slowly and steady being re-opened on a well by well basisOperated by Selva Maria Oil on behalf of IOX until local authorities approves operator’s licence.***************************Interoil Exploration and Production ASA is a Norwegian based exploration and production company – listed on the Oslo Stock Exchange – with focus on Latin America. The Company is operator and license holder of several production and exploration assets in Colombia and Argentina. Interoil currently employs approximately 50 people and is headquartered in Oslo.This information is subject to the disclosure requirements pursuant to section...

FREMONT, Calif., June 13, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that new post-hoc efficacy analyses of QtryptaTM, Zosano’s lead investigational product candidate for the acute treatment of migraine, will be presented as a virtual oral presentation on the 2020 American Headache Society’s Virtual Annual Scientific Meeting Platform.Six different measurements of pain reduction from the exploratory efficacy results in the long-term safety study (“LTSS”) were examined and compared to the positive clinical results observed in the Phase 2/3 Zotrip study.  Across all six efficacy measurements, which included pain freedom and pain relief at 2 hours, clinical activity observed in the LTSS during the one-year trial period treating approximately 6,000 attacks...

Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive adult leukaemia live longer compared to azacitidine aloneData will be presented as a late-breaking abstract at the 25th European Hematology Association Virtual CongressBasel, 13 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual Congress Press Briefing on Saturday 13 June 2020 at 08:30 CEST and will be presented at the congress during the Late-breaking Oral Session (abstract...

Regulated InformationNyrstar releases notice for the two Extraordinary General Shareholders’ Meetings to be held on 30 June 202013 June 2020 at 07.00 CESTAs announced in detail on Wednesday 10 June 2020, Nyrstar NV (the “Company”) today issued the notice for the two extraordinary general shareholders’ meetings to be held on 30 June 2020.In accordance with the press release of the Company of 10 June 2020, the meetings will be held with the same practical modalities and procedure as the annual general meeting scheduled on 30 June 2020 and therefore in a virtual format in accordance with the Royal Decree no. 4 of 9 April 2020 containing various provisions on co-ownership and company and association law in the context of the fight against the Covid-19 pandemic (the “Royal Decree no. 4”), where shareholders are also offered the possibility...

Gereglementeerde InformatieNyrstar publiceert de oproeping voor de twee Buitengewone Algemene Aandeelhoudersvergaderingen te houden op 30 juni 202013 juni 2020 om 07.00 CESTZoals in detail aangekondigd op woensdag 10 juni 2020, publiceerde Nyrstar NV (de “Vennootschap”) vandaag de oproeping voor de twee buitengewone algemene aandeelhoudersvergaderingen te houden op 30 juni 2020.Overeenkomstig het persbericht van de Vennootschap van 10 juni 2020, zullen de vergaderingen georganiseerd worden met dezelfde praktische modaliteiten en procedure als de gewone algemene vergadering gepland op 30 juni 2020 en zullen daarom zonder fysieke aanwezigheid gehouden worden overeenkomstig het Koninklijk Besluit nr. 4 van 9 april 2020 houdende diverse bepalingen inzake mede-eigendom en vennootschaps- en verenigingsrecht in het kader van de strijd tegen...

VANCOUVER, British Columbia, June 12, 2020 (GLOBE NEWSWIRE) — SHARC™ International Systems Inc.  (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) has filed its financial results for the three months ended March 31, 2020 (“Q1 2020”) and 2019 (“Q1 2019”). All figures are in CDN unless otherwise noted.Q1 2020 Financial Highlights:Quarter over quarter revenue growth of 182% or an increase of $0.04M and comparative quarter over quarter revenue growth of 93% or an increase of $0.03M. Adjusted EBITDA1 Loss of $0.47M compared to $0.58M in Q1 2019. The Company has reduced its working capital deficit by approximately $2.0M, from $3.5M at December 31, 2019 to $1.5M at March 31, 2020. Furthermore, this represents a total $3.6M reduction in working capital deficit from $5.1M at September 30, 2019. Gross margin...

Extraction-Free, Real-Time PCR Workflow with Capacity of Up to 6,000 Tests per DayEasy-to-Administer Saliva Test Would Eliminate Need for Invasive Nasopharyngeal SwabHigh-Throughput Assay Developed in Collaboration with Washington University School of MedicineSOUTH SAN FRANCISCO, Calif., June 12, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced it has filed for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for an extraction-free saliva-based test to detect the SARS‑CoV‑2 virus. The test, developed in collaboration with scientists at the McDonnell Genome Institute and the Department of Genetics at Washington University School of Medicine in St. Louis, provides...

NEW YORK, June 12, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that DocuSign, Inc. (Nasdaq: DOCU), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the NASDAQ-100 Technology Sector Index (Nasdaq: NDXT) prior to market open on Monday, June 22, 2020. DocuSign, Inc. will replace United Airlines Holdings, Inc. (Nasdaq: UAL) in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index. United Airlines Holdings, Inc. will be also be removed from the NASDAQ-100 Ex-Tech Sector Index (Nasdaq: NDXX) prior to market open on Monday, June 22, 2020.For more information about the company, go to https://www.docusign.com/.About NasdaqNasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering...